Management of Postthrombolysis Hemorrhagic and Orolingual Angioedema Complications

Cumara B. O'carroll, Maria I. Aguilar

Research output: Contribution to journalReview article

10 Citations (Scopus)

Abstract

Intravenous recombinant tissue plasminogen activator was first approved for the treatment of acute ischemic stroke in the United States in 1996. Thrombolytic therapy has been proven to be effective in acute ischemic stroke treatment and shown to improve long-term functional outcomes. Its use is associated with an increased risk of symptomatic intracerebral hemorrhage as well as orolingual angioedema. Our goal is to outline the management strategies for these postthrombolysis complications.

Original languageEnglish (US)
Pages (from-to)133-141
Number of pages9
JournalThe Neurohospitalist
Volume5
Issue number3
DOIs
StatePublished - 2015

Fingerprint

Angioedema
Stroke
Thrombolytic Therapy
Cerebral Hemorrhage
Tissue Plasminogen Activator
Therapeutics

Keywords

  • cerebrovascular disorders
  • clinical specialty
  • intracranial hemorrhages
  • neurohospitalist
  • stroke

ASJC Scopus subject areas

  • Clinical Neurology

Cite this

Management of Postthrombolysis Hemorrhagic and Orolingual Angioedema Complications. / O'carroll, Cumara B.; Aguilar, Maria I.

In: The Neurohospitalist, Vol. 5, No. 3, 2015, p. 133-141.

Research output: Contribution to journalReview article

O'carroll, Cumara B. ; Aguilar, Maria I. / Management of Postthrombolysis Hemorrhagic and Orolingual Angioedema Complications. In: The Neurohospitalist. 2015 ; Vol. 5, No. 3. pp. 133-141.
@article{60f86a4a5b3b4b6cb0009745c407991e,
title = "Management of Postthrombolysis Hemorrhagic and Orolingual Angioedema Complications",
abstract = "Intravenous recombinant tissue plasminogen activator was first approved for the treatment of acute ischemic stroke in the United States in 1996. Thrombolytic therapy has been proven to be effective in acute ischemic stroke treatment and shown to improve long-term functional outcomes. Its use is associated with an increased risk of symptomatic intracerebral hemorrhage as well as orolingual angioedema. Our goal is to outline the management strategies for these postthrombolysis complications.",
keywords = "cerebrovascular disorders, clinical specialty, intracranial hemorrhages, neurohospitalist, stroke",
author = "O'carroll, {Cumara B.} and Aguilar, {Maria I.}",
year = "2015",
doi = "10.1177/1941874415587680",
language = "English (US)",
volume = "5",
pages = "133--141",
journal = "The Neurohospitalist",
issn = "1941-8744",
publisher = "Sage Publications",
number = "3",

}

TY - JOUR

T1 - Management of Postthrombolysis Hemorrhagic and Orolingual Angioedema Complications

AU - O'carroll, Cumara B.

AU - Aguilar, Maria I.

PY - 2015

Y1 - 2015

N2 - Intravenous recombinant tissue plasminogen activator was first approved for the treatment of acute ischemic stroke in the United States in 1996. Thrombolytic therapy has been proven to be effective in acute ischemic stroke treatment and shown to improve long-term functional outcomes. Its use is associated with an increased risk of symptomatic intracerebral hemorrhage as well as orolingual angioedema. Our goal is to outline the management strategies for these postthrombolysis complications.

AB - Intravenous recombinant tissue plasminogen activator was first approved for the treatment of acute ischemic stroke in the United States in 1996. Thrombolytic therapy has been proven to be effective in acute ischemic stroke treatment and shown to improve long-term functional outcomes. Its use is associated with an increased risk of symptomatic intracerebral hemorrhage as well as orolingual angioedema. Our goal is to outline the management strategies for these postthrombolysis complications.

KW - cerebrovascular disorders

KW - clinical specialty

KW - intracranial hemorrhages

KW - neurohospitalist

KW - stroke

UR - http://www.scopus.com/inward/record.url?scp=84992886357&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84992886357&partnerID=8YFLogxK

U2 - 10.1177/1941874415587680

DO - 10.1177/1941874415587680

M3 - Review article

AN - SCOPUS:84992886357

VL - 5

SP - 133

EP - 141

JO - The Neurohospitalist

JF - The Neurohospitalist

SN - 1941-8744

IS - 3

ER -